http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2559432-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a99f430409aa1d32a4ba48b12e0637e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
filingDate 2010-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19c086345a281b4689099d0396fe677f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99f89428088ce94c1ce00e27463662f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbc3d7a0d73fdaf889c4037da8a6a1e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04505414ca1d0b5c5611873f84ade6bb
publicationDate 2013-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2559432-A1
titleOfInvention Means for the prophylaxis and treatment of acute and chronic pancreatitis
abstract The invention relates to drugs for the prophylaxis and treatment of acute and chronic pancreatitis. n The technical result from the application of the drug proposed for prophylaxis and treatment of acute and chronic pancreatitis consists in the elimination of inflammation and stimulation of the regeneration of pancreas cells. n The drug for the treatment of acute and chronic pancreatitis contains at least one polyprenyl phosphate or polyprenyl pyrophosphate with a number of isoprene units from 7 to 30 or a mixture of different polyprenyl phosphates and polyprenyl pyrophospates.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021062347-A1
priorityDate 2010-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6525035-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0350801-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0548825-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4613593-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0699440-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6400441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414064869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407043279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454024603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226440653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID383413

Total number of triples: 41.